Evaluation of Single Nucleotide Polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT)

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 2, 2011, Pages 385-391

  Haffty, Bruce G ^a,d   Goyal, Sharad ^a   Kulkarni, Diptee ^a   Green, Camille ^a   Vazquez, Alexi ^a   Schiff, Devora ^a   Moran, Meena S ^b   Yang, Qifeng ^c   Ganesan, Shridar ^a   Hirsfield, Kim M ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY   (United States)

^c SHANDONG UNIVERSITY   (China)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Breast cancer; Breast conserving surgery; Local recurrence, 53BP1; Single nucleotide polymorphism

Indexed keywords

BINDING PROTEINS; BREAST CANCER; BREAST CONSERVING SURGERY; CRITICAL VARIABLES; DAMAGE REPAIR; DEOXYRIBONUCLEIC ACIDS; ESTROGEN RECEPTOR; KEY COMPONENT; LOCAL RECURRENCE; MEAN AGES; PREMENOPAUSAL WOMEN; RADIATION-INDUCED; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISMS; VALIDATION STUDY; WHOLE-BREAST IRRADIATION;

DISEASES; DNA; IRRADIATION; NUCLEIC ACIDS; NUCLEOTIDES; ORGANIC ACIDS; PATIENT MONITORING; RADIOTHERAPY; SURGERY;

GENES;

BINDING PROTEIN; CYTOSINE; ESTROGEN RECEPTOR; GENOMIC DNA; GUANINE; PROTEIN P53; PROTEIN P53 BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RELAPSE; CAUCASIAN; CORRELATION ANALYSIS; DNA DAMAGE; DNA DETERMINATION; DNA REPAIR; FEMALE; GENE FREQUENCY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE BREAST IRRADIATION;

ADULT; ALLELES; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DNA DAMAGE; DNA REPAIR; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MASTECTOMY, SEGMENTAL; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENOPAUSE;

EID: 79955608005     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.02.005     Document Type: Article

References (71)

1. H. Bartelink, J.C. Horiot, and P. Poortmans Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation N Engl J Med 345 2001 1378 1387
2. A. de la Rochefordiere, B. Asselain, and F. Campana Age as prognostic factor in premenopausal breast carcinoma Lancet 341 1993 1039 1043 (Pubitemid 23114394)
3. B.L. Fowble, D.J. Schultz, and B. Overmoyer The influence of young age on outcome in early stage breast cancer Int J Radiat Oncol Biol Phys 30 1994 23 33 (Pubitemid 24291110)
4. J.A. Haas, D.J. Schultz, and M.E. Peterson An analysis of age and family history on outcome after breast-conservation treatment: The University of Pennsylvania experience Cancer J Sci Am 4 1998 308 315
5. J. Harris, M. Lippman, and M. Morrow Diseases of the breast 3rd ed. 2004 Lippincott Williams and Wilkins Philadelphia
6. A. Recht Selection of patients with early stage invasive breast cancer for treatment with conservative surgery and radiation therapy Semin Oncol 23 1996 19 30 (Pubitemid 26105767)
7. T.A. Buchholz, S.L. Tucker, and J. Erwin Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy J Clin Oncol 19 2001 2240 2246 (Pubitemid 32372325)
8. B. Fowble Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer Acta Oncol 38 Suppl. 13 1999 9 17
9. G.M. Freedman, P.R. Anderson, and T. Li Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
10. B.G. Haffty, D. Fischer, and M. Rose Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data J Clin Oncol 9 1991 997 1003
11. B.G. Haffty, L. Wilmarth, and L. Wilson Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient Cancer 73 1994 2543 2548 (Pubitemid 24155531)
12. B.G. Haffty, Q. Yang, and M.S. Moran Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation Int J Radiat Oncol Biol Phys 71 2008 1006 1013
13. B.G. Haffty, Q. Yang, and M. Reiss Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657 (Pubitemid 46631305)
14. A. Recht, and M.J. Houlihan Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review Ann Surg 222 1995 9 18
15. U. Veronesi, E. Marubini, and M. Del Vecchio Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events J Natl Cancer Inst 87 1995 19 27
16. F.A. Vicini, A. Recht, and A. Abner Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer J Natl Cancer Inst Monogr 1992 33 39
17. T.E. Alpert, and B.G. Haffty Conservative management of breast cancer in BRCA1/2 mutation carriers Clin Breast Cancer 5 2004 37 42 (Pubitemid 38821189)
18. B.G. Haffty, E. Harrold, and A.J. Khan Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 2002 1471 1477 (Pubitemid 34457765)
19. L.J. Pierce, A.M. Levin, and T.R. Rebbeck Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol 24 2006 2437 2443 (Pubitemid 46630619)
20. L.J. Pierce, M. Strawderman, and S.A. Narod Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol 18 2000 3360 3369
21. C. Seynaeve, L.C. Verhoog, and L.M. Van De Bosch Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy Eur J Cancer 40 2004 1150 1158 (Pubitemid 38526333)
22. L. Mellemkjaer, C. Dahl, and J.H. Olsen Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study Br J Cancer 98 2008 728 733 (Pubitemid 351272614)
23. Effects of radiotherapy and surgery in early breast cancer An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group N Engl J Med 333 1995 1444 1455
24. I. Gage, S.J. Schnitt, and A.J. Nixon Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy Cancer 78 1996 1921 1928 (Pubitemid 26360575)
25. K.J. Halverson, C.A. Perez, and M.E. Taylor Age as a prognostic factor for breast and regional nodal recurrence following breast conserving surgery and irradiation in stage I and II breast cancer Int J Radiat Oncol Biol Phys 27 1993 1045 1050 (Pubitemid 23361582)
26. E. Obedian, and B.G. Haffty Negative margin status improves local control in conservatively managed breast cancer patients Cancer J Sci Am 6 2000 28 33 (Pubitemid 30078503)
27. A. Recht Lessons of studies of breast-conserving therapy with and without whole-breast irradiation for patient selection for partial-breast irradiation Semin Radiat Oncol 15 2005 123 132 (Pubitemid 40439242)
28. A. Recht, J.L. Connolly, and S.J. Schnitt The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy Int J Radiat Oncol Biol Phys 14 1988 3 10 (Pubitemid 18059122)
29. F.A. Vicini, L.L. Kestin, and N.S. Goldstein Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy J Surg Oncol 76 2001 245 254 (Pubitemid 32381680)
30. M.E. Robson, J. Boyd, and P.I. Borgen Hereditary breast cancer Curr Probl Surg 38 2001 387 480
31. D.H. Choi, D.Y. Cho, and M.H. Lee The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation Breast Cancer Res Treat 112 2008 569 573
32. R. Nusbaum, K.J. Vogel, and K. Ready Susceptibility to breast cancer: Hereditary syndromes and low penetrance genes Breast Dis 27 2006 21 50
33. T. Ripperger, D. Gadzicki, and A. Meindl Breast cancer susceptibility: Current knowledge and implications for genetic counselling Eur J Hum Genet 17 2009 722 731
34. G.L. Bond, K.M. Hirshfield, and T. Kirchhoff MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner Cancer Res 66 2006 5104 5110 (Pubitemid 43844932)
35. W. Schroth, M.P. Goetz, and U. Hamann Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen JAMA 302 2009 1429 1436
36. B. Frank, K. Hemminki, and J.L. Bermejo TP53-binding protein variants and breast cancer risk: A case-control study Breast Cancer Res 7 2005 R502 R505
37. K. Iwabuchi, M. Hashimoto, and T. Matsui 53BP1 contributes to survival of cells irradiated with X-ray during G1 without Ku70 or Artemis Genes Cells 11 2006 935 948 (Pubitemid 44084028)
38. K. Rapakko, K. Heikkinen, and S.M. Karppinen Germline alterations in the 53BP1 gene in breast and ovarian cancer families Cancer Lett 245 2007 337 340 (Pubitemid 44959367)
39. M.M. Adams, and P.B. Carpenter Tying the loose ends together in DNA double strand break repair with 53BP1 Cell Div 1 2006 19
40. H. Ma, Z. Hu, and X. Zhai Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population Carcinogenesis 27 2006 766 771
41. B.G. Haffty, D. Fischer, and J.J. Fischer Regional nodal irradiation in the conservative treatment of breast cancer Int J Radiat Oncol Biol Phys 19 1990 859 865 (Pubitemid 20345152)
42. B. Devlin, and N. Risch A comparison of linkage disequilibrium measures for fine-scale mapping Genomics 29 1995 311 322
43. A. de la Chapelle Genetic predisposition to human disease: Allele-specific expression and low-penetrance regulatory loci Oncogene 28 2009 3345 3348
44. E.N. Imyanitov Gene polymorphisms, apoptotic capacity and cancer risk Hum Genet 125 2009 239 246
45. P. Tan Germline polymorphisms as modulators of cancer phenotypes BMC Med 6 2008 27
46. D.A. Kulkarni, A. Vazquez, and B.G. Haffty A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer Carcinogenesis 30 2009 1910 1915
47. J. Jiang, X. Zhang, and H. Yang Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology Methods Mol Biol 471 2009 305 333
48. C. Kiyohara, and K. Yoshimasu Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis Int J Med Sci 4 2007 59 71 (Pubitemid 46238636)
49. R.L. Milne, W. Greenhalf, and C. Murta-Nascimento The inherited genetic component of sporadic pancreatic adenocarcinoma Pancreatology 9 2009 206 214
50. S. Mocellin, D. Verdi, and D. Nitti DNA repair gene polymorphisms and risk of cutaneous melanoma: A systematic review and meta-analysis Carcinogenesis 30 2009 1735 1743
51. I. Rappold, K. Iwabuchi, and T. Date Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways J Cell Biol 153 2001 613 620 (Pubitemid 34280146)
52. T. Rauch, X. Zhong, and G.P. Pfeifer 53BP1 is a positive regulator of the BRCA1 promoter Cell Cycle 4 2005 1078 1083
53. A.Y. Ho, D.P. Atencio, and S. Peters Genetic predictors of adverse radiotherapy effects: The Gene-PARE project Int J Radiat Oncol Biol Phys 65 2006 646 655 (Pubitemid 43795849)
54. C.M. Iannuzzi, D.P. Atencio, and S. Green ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects Int J Radiat Oncol Biol Phys 52 2002 606 613 (Pubitemid 34158720)
55. S.M. Rakfal, and M. Deutsch Radiotherapy for malignancies associated with lupus: Case reports of acute and late reactions Am J Clin Oncol 21 1998 54 57 (Pubitemid 28092973)
56. X. Yuan, Z. Liao, and Z. Liu Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy J Clin Oncol 27 2009 3370 3378
57. R. Krupa, E. Synowiec, and E. Pawlowska Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer Exp Mol Pathol 87 2009 32 35
58. D.L. Skerrett, E.M. Moore, and D.S. Bernstein Cytokine genotype polymorphisms in breast carcinoma: Associations of TGF-beta1 with relapse Cancer Invest 23 2005 208 214 (Pubitemid 40770738)
59. G.F. Lehnerdt, P. Franz, and A. Bankfalvi The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma Ann Oncol 20 2009 1094 1099
60. H. Hirata, Y. Hinoda, and N. Kikuno Bcl2-938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy J Urol 181 2009 1907 1912
61. C. Camps, R. Sirera, and V. Iranzo Gene expression and polymorphisms of DNA repair enzymes: Cancer susceptibility and response to chemotherapy Clin Lung Cancer 8 2007 369 375 (Pubitemid 46924057)
62. S. Dulucq, S. Bouchet, and B. Turcq Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia Blood 112 2008 2024 2027
63. J. George, K. Dharanipragada, and S. Krishnamachari A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer Clin Breast Cancer 9 2009 161 165
64. F. Ma, T. Sun, and Y. Shi Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib Lung Cancer 66 2009 114 119
65. P. Pacetti, E. Giovannetti, and A. Mambrini Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine Anticancer Res 29 2009 1835 1840
66. Z.E. Sauna, C. Kimchi-Sarfaty, and S.V. Ambudkar Silent polymorphisms speak: How they affect pharmacogenomics and the treatment of cancer Cancer Res 67 2007 9609 9612 (Pubitemid 47621204)
67. A.M. Schultheis, G. Lurje, and K.E. Rhodes Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab Clin Cancer Res 14 2008 7554 7563
68. Z. Wang, B. Xu, and D. Lin XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population Lung Cancer 62 2008 99 104
69. U. Warnecke-Eberz, D. Vallbohmer, and H. Alakus ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer J Gastrointest Surg 13 2009 1411 1421
70. X. Wu, C. Lu, and Y. Ye Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy Pharmacogenet Genomics 18 2008 955 965
71. J. Ragoussis Genotyping technologies for genetic research Annu Rev Genomics Hum Genet 10 2009 117 133